Evidence map›Paper›PMID 32265004›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2020

Specialist laboratory networks as preparedness and response tool - the Emerging Viral Diseases-Expert Laboratory Network and the Chikungunya outbreak, Thailand, 2019.

Giulietta Venturi, Stephan W Aberle, Tatjana Avšič-Županc, Luisa Barzon, Christoph Batejat, Elisa Burdino, Fabrizio Carletti, Rémi Charrel, Iva Christova, Jeff Connell and 22 more

Abstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Excellent capability for molecular detection ofJournal of clinical microbiology · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Giulietta VenturiDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Stephan W AberleCenter for Virology, Medical University of Vienna, Vienna, Austria.
Tatjana Avšič-ŽupancInstitute of Microbiology and Immunology, Faculty of Medicine, Ljubljana, Slovenia.
Luisa BarzonDepartment of Molecular Medicine, University of Padova, Padova, Italy.
Christoph BatejatLaboratory for Urgent Response to Biological Threats (CIBU), Institut Pasteur, Paris, France.
Elisa BurdinoLaboratory of Microbiology and Virology, Amedeo di Savoia Hospital, Turin, Italy.
Fabrizio CarlettiNational Institute for Infectious Diseases 'Lazzaro Spallanzani' IRCCS, Rome, Italy.
Rémi CharrelUnité des Virus Emergents (UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IRBA, IHU Méditerranée Infection), Marseille, France.
Iva ChristovaNational Reference Vector-borne pathogens Laboratory, National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria.
Jeff ConnellNational Virus Reference Laboratory, University College Dublin, Ireland.
Victor Max CormanDepartment of Virology, Labor Berlin, Charité-Vivantes GmbH, Berlin, Germany.
Mary EmmanouilDiagnostic Services Laboratory, Public Health Laboratories, Hellenic Pasteur Institute, Athens, Greece.
Anne J JääskeläinenVirology and Immunology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Ivan KuroltResearch unit, University Hospital for Infectious Diseases 'Dr. Fran Mihaljević', Zagreb, Croatia.
Yaniv LustigCentral Virology Laboratory, Ministry of Health, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
Miguel J MartinezISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Marion KoopmansDepartment of Viroscience, Erasmus Medical Centre, Rotterdam, the Netherlands.
Orsolya NagyDepartment of Virology, National Public Health Center, Budapest, Hungary.
Trung NguyenDépartement de Microbiologie, Laboratoire national de santé, Luxemburg.
Anna PapaDepartment of Microbiology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Mercedes Pérez-RuizServicio de Microbiología, Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitaria, Granada, Spain.
Martin PfefferInstitute of Animal Hygiene and Veterinary Public Health, Leipzig, Germany.
Jelena ProticNational Reference Laboratory for ARBO viruses and haemorrhagic fever, Belgrade, Serbia.
Johan ReimerinkCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Giada RossiniRegional Reference Centre for Microbiological Emergencies (CRREM), Unit of Clinical Microbiology, St Orsola Malpighi Hospital, Bologna, Italy.
María Paz Sánchez-Seco FariñasCentro Nacional de Microbiología. Instituto de Salud Carlos III, Madrid, España.
Jonas Schmidt-ChanasitWHO Collaborating Centre for Arbovirus and Haemorrhagic Fever Reference and Research, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Sandra SöderholmDepartment of Microbiology, The Public Health Agency of Sweden, Solna, Sweden.
Bertrand SudreEuropean Centre for Disease Prevention and Control, Solna, Sweden.
Marjan Van EsbroeckDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
CHIKV-Working GroupThe members of the CHIKV-Working Group are listed at the end of the article.
Chantal B ReuskenDepartment of Viroscience, Erasmus Medical Centre, Rotterdam, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We illustrate the potential for specialist laboratory networks to be used as preparedness and response tool through rapid collection and sharing of data. Here, the Emerging Viral Diseases-Expert Laboratory Network (EVD-LabNet) and a laboratory assessment of chikungunya virus (CHIKV) in returning European travellers related to an ongoing outbreak in Thailand was used for this purpose. EVD-LabNet rapidly collected data on laboratory requests, diagnosed CHIKV imported cases and sequences generated, and shared among its members and with the European Centre for Disease Prevention and Control. Data across the network showed an increase in CHIKV imported cases during 1 October 2018-30 April 2019 vs the same period in 2018 (172 vs 50), particularly an increase in cases known to be related to travel to Thailand (72 vs 1). Moreover, EVD-LabNet showed that strains were imported from Thailand that cluster with strains of the ECSA-IOL E1 A226 variant emerging in Pakistan in 2016 and involved in the 2017 outbreaks in Italy. CHIKV diagnostic requests increased by 23.6% between the two periods. The impact of using EVD-LabNet or similar networks as preparedness and response tool could be improved by standardisation of the collection, quality and mining of data in routine laboratory management systems.

Indexed as

Chikungunya FeverChikungunya virusCommunicable Diseases, EmergingDisease NotificationDisease OutbreaksHumansLaboratoriesPhylogenyThailandTravelchikungunyaEVD-LabNetlab preparedness and responselab surveillanceThailandtravel

Identifiers

PMID32265004
PMCPMC7140599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.